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Abstract Genus Salvia, commonly known as sage, is the
largest genus in the Lamiaceae family. It comprises many
species traditionally used as brain-enhancing tonics.
In vitro and animal studies have confirmed that several
Salvia species contain a large array of active compounds
that may enhance cognitive activity and protect against
neurodegenerative disease. In this review, the active con-
stituents in plants belonging to the genus Salvia are sum-
marised, and their influence on pharmacodynamics
pertinent to cognitive activity are detailed. In particular, the
effects of plants belonging to the genus Salvia and their
constituents on cognitive skills including memory, atten-
tion and learning are detailed. Their potential effects in
dementia, including Alzheimer’s disease, are also exam-
ined. Completed human trials are summarised, and factors
influencing the potency of Salvia plants are covered.
Finally, directions for future research are proposed to
enhance our understanding of the potential health benefits
of Salvia plants.
Key Points
Salvia plants and their constituents can influence
several biological mechanisms associated with
cognition including their effects on amyloid-b,
cholinergic activity, neurotrophins, oxidative stress,
inflammation and anxiolytic/antidepressant
behaviours.
Several studies have confirmed the many Salvia
species have promising, cognitive-enhancing effects
in human adults.
Further research is required to examine the longer-
term cognitive-enhancing effects of Salvia species
on cognition, memory and the treatment of
neurodegenerative diseases such as Alzheimer’s
disease.
1 Introduction
Cognition refers to mental actions associated with acquir-
ing knowledge. It encompasses processes associated with
attention, memory, judgment and evaluation, reasoning,
problem solving and decision making. Interest in herbal
remedies as cognitive-enhancing agents (often referred to
as nootropics) is on the increase with several promising
compounds available, including curcumin, Ginkgo biloba
and Bacopa monnieri. The genus Salvia (sage) is the lar-
gest genus of plants in the Lamiaceae family, comprising
over 900 species distributed throughout the world.
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Common species include S. officinalis (common sage), S.
miltiorrhiza (Chinese sage), S. lavandulaefolia (Spanish
sage), S. fruticose (Greek sage), S. sclarea (clary sage) and
S. hispanica (chia).
Salvia officinalis comes from the Latin word meaning
‘to heal’ and is widely used in both culinary and medicinal
preparations. Many species of Salvia are native to
Mediterranean Europe and have been traditionally used for
the treatment of a range of problems including digestive
and circulation disturbances, bronchitis, coughs, asthma,
memory problems, angina, mouth and throat inflammation,
depression and excessive sweating. Salvia plants are tra-
ditionally noted for their antioxidant effects and ability to
enhance ‘head and brain’ function, improve memory,
quicken the senses, and delay age-associated cognitive
decline [1].
In this review, the active constituents in plants
belonging to the genus Salvia are summarised, and their
influence on pharmacodynamic activity pertinent to
cognition are detailed. In particular, the effects of plants
belonging to the genus Salvia and their constituents on
cognitive skills including memory, attention and learning
are detailed. Their potential effects in dementia,
including Alzheimer’s disease, are also reviewed. Com-
pleted human trials are summarised, and factors influ-
encing the potency of Salvia plants are covered. Finally,
directions for future research are proposed to enhance
our understanding of the potential health benefits of
Salvia plants.
2 Active Constituents in Salvia Species
As detailed in Table 1, Salvia plants are a rich source of
polyphenol compounds with over 160 identified polyphe-
nols, comprising an array of phenolic acids and flavonoids.
These phenolic compounds include caffeic acid and its
derivatives, rosmarinic acid, salvianolic acids, sage-
coumarin, lithospermic acids, sagernic acid, and yunnaneic
acids. The most prevalent flavonoids include luteolin,
apigenin, hispidulin, kaempferol and quercetin [2]. Plants
of the genus Salvia are also rich in essential oils, with a
large array of terpenoids including a and b-thujone, cam-
phor, 1,8-cineole, a-humulene, b-caryophyllene and virid-
iflorol. Moreover, they are rich sources of diterpenes and
triterpenes such as carnosic acid, ursolic acid, carnosol and
tanshinones.
The composition of the polyphenols and terpenoids can
vary considerably across Salvia species. For example,
rosmarinic acid is high in S. officinalis but low in S.
hypoleuka [3]. Levels of thujone are also reported to be
higher in S. officinalis compared with S. lavandulaefolia
[4]. Tanshinones are found in S. miltiorrhiza [5], and
varying forms of yunnaneic acids and salvianolic acids
differ across Salvia species.
3 Salvia and its Pharmacodynamic Influences
on the Brain
Cognitive activity and performance can be influenced
by an array of neurological and biochemical factors.
Damage to specific neurological structures can be
associated with specific cognitive deficits, and there is
an increasing awareness of the influence of different
hormones and neurotransmitters on cognitive activity.
Because of its rich array of chemical constituents,
plants of genus Salvia can influence multiple physio-
logical pathways (summarised in Fig. 1). Those espe-
cially pertinent to cognition are summarised in the
following sections.
Table 1 Common compounds identified in Salvia species
Phenolic acids Caffeic acid, rosmarinic acid, salvianolic acids,
sagecoumarin, lithospermic acid, sagerinic acid,
yunnaneic acids
Flavonoids Luteolin, apigenin, hispidulin, kaempferol,
quercetin
Terpenoids a and b-Thujone, camphor, 1,8-cineole, a-
humulene, b-caryophyllene, viridiflorol, carnosic
acid, ursolic acid, carnosol, tanshinones
Polysaccharides Arabinogalactans, pectin Fig. 1 Major components in Salvia species and their pharmacody-
namic effects in the brain
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3.1 Salvia and Amyloid-b
The accumulation of the amyloid-b peptide (Ab) is a
characteristic of Alzheimer’s disease and its deposition is
considered partially responsible for the cognitive dys-
function seen in Alzheimer’s disease. It is theorised that
aggregated Ab is accountable for the progressive nature of
the disease, as the unregulated build-up of aggregates are
neurotoxic, causing dysfunction to cholinergic neurons and
calcium homeostasis, and promoting the formation of
reactive oxygen species (ROS) and pro-inflammatory
responses. Ab are known to cause specific learning and
memory impairment and its administration has been
renowned for inducing memory loss in animal models [6].
Salvia miltiorrhiza has been shown to protect mice from
Ab-induced neurotoxicity by inhibiting increases in tumour
necrosis factor-a (TNF-a), interleukin-6 (IL-6) levels and
acetylcholinesterase (AChE) activity [7]. Tanshinones
from S. miltiorrhiza can also protect against Ab-induced
toxicity by ameliorating mRNA expression of inducible
nitric oxide synthase (iNOS), matrix metalloproteinase 2
and nuclear transcription factor-j [8].
Animal studies have demonstrated that supplementation
with S. sahendica attenuated memory deficits, modulated
cAMP response element binding protein and its down-
stream molecules and decreased apoptosis in Ab-injected
rats [9]. In mice exposed to an acute injection of Ab,
rosmarinic acid also prevented Ab-induced nitration of
proteins (an indirect indicator of peroxynitrite damage) in
the hippocampus. Rosmarinic acid also prevented memory
impairments induced by Ab toxicity [10]. Protective effects
from Ab toxicity have also been observed following the
administration of the Salvia constituents, salvianolic acid
[11], carnosic acid [12] and quercetin [13].
3.2 Salvia and Cholinergic Activity
Central cholinergic signalling has long been associated
with features of memory, motivation and mood. Acetyl-
choline (ACh), a neurotransmitter involved in cholinergic
signalling, is believed to play an important role in several
aspects of cognitive function and behaviour, including
attention, learning, memory and motivation. Alterations in
ACh signalling are involved in the pathophysiology of
multiple neurodegenerative disorders including Alzhei-
mer’s disease [14]. Recent studies have also provided
support for a role of cortical ACh in attentional effort,
orientation and the detection of behaviourally significant
stimuli [15].
AChE is an enzyme that catalyses the breakdown of
acetylcholine and there are several AChE inhibitor drugs
available to increase overall ACh concentration. These
drugs are based on the premise that increasing the
availability of ACh at acetylcholine receptors in the brain
enhances neuron-to-neuron transport and ultimately
improves cognitive function [16].
In vitro and animal studies have revealed that several
Salvia species and their constituents are effective AChE
inhibitors. An aqueous extract of S. officinalis lowered
AChE activity in mice [17], and in vitro analyses revealed
that ethanolic extracts of S. officinalis reduced AChE, with
greater effects on butyrylcholinesterase [18, 19]. In mice
subjected to Ab peptide, pre-treatment with S. sahendica
significantly ameliorated reductions in AChE activity and
memory performance [20]. The essential oil of S. fruticosa
also showed inhibition against AChE [21], and similar
findings were revealed from the essential oil of S. lavan-
dulaefolia, although AChE inhibiting activity occurred
exclusively via the monoterpernoids [22]. AChE inhibition
has also been observed from the phenolic diterpenes, 7a-
methoxyrosmanol and isorosmanol, isolated from S. offic-
inalis. [23]. The active constituents, rosmarinic acid, car-
nosic acid and quercetin, found in several Salvia species
can also inhibit AChE activity [23–25]. The tanshinones
from S. miltiorrhiza also inhibit both AChE and butyryl-
cholinesterase activity [26, 27].
3.3 Salvia and Neurotrophins
Neurotrophins are important regulators of neural survival,
development, function and plasticity [28]. Brain-derived
neurotrophic factor (BDNF) is one neutrophin that has
received particular attention in cognitive and neurological
research due to its role in supporting the survival of
existing neurons, encouraging the growth and differentia-
tion of new neurons and synapses, and enhancing learning
and memory [29]. In a recent meta-analysis, peripheral
BDNF levels were confirmed to be lower in patients with
Alzheimer’s disease and mild cognitive impairment [30].
In one study, the administration of S. miltiorrhiza to
mice mitigated Ab-induced reductions in BDNF [7]. Ros-
marinic acid also protected against memory deficits
induced by cerebral artery occlusion in mice. One mech-
anism of the neuroprotective effects of rosmarinic acid
involved an increase in BDNF [31]. In rats exposed to
chronic unpredictable stress, rosmarinic acid restored hip-
pocampal BDNF. Moreover, in vitro experiments revealed
that rosmarinic acid increased BDNF levels in cultured
astrocytes [32].
Caffeic acid reduced immobility time of mice in the
forced swim test and ameliorated stress-induced reductions
in levels of BDNF mRNA in the frontal cortex. Caffeic
acid did not modify the levels of BDNF in brain regions of
naive mice, indicating that it primarily attenuates the
down-regulation of BDNF transcription during stressful
conditions [33].
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The flavonoid luteolin was identified to be highly active
in inducing the synthesis and secretion of neurotrophic
factors, including nerve growth factor, glial-derived neu-
rotrophic factor and BDNF in cultured astrocytes [34].
There have also been some reports that quercetin can
increase BDNF levels in brain injury models [35]. The
production of nerve growth factor, another neurotrophin
important for the growth, maintenance and survival of
neurons, has also been shown to be enhanced by carnosic
acid, carnosol [36], tanshinones [37] and quercetin [38].
3.4 Salvia and Antioxidant Effects
Excess free radical activity and reduced antioxidant
defences create a state of oxidative stress. Over time,
oxidative stress can damage all body tissues, with the brain
particularly susceptible. Oxidative stress has been impli-
cated in many neurological disorders including Alzhei-
mer’s disease [39] and Parkinson’s disease [40]. Oxidative
stress is also elevated in many mental health disorders
including major depressive disorder [41] and attention-
deficit hyperactivity disorder (ADHD) [42]. Moreover,
animal models of induced oxidative stress have confirmed
that it can adversely influence memory and learning per-
formance [43, 44].
Salvia plants and their individual constituents possess
strong antioxidant activity. In an analysis of 10 Salvia
species, it was confirmed that all species exhibited signif-
icant antioxidant activity as measured by oxygen radical
absorbance capacity, radical scavenging capacity and total
phenolic content. The extent of antioxidant activity varied
across species and extraction methods used, the ethanolic
extract of S. officinalis exhibited the highest activity [45].
It has been confirmed that S. miltiorrhiza can reduce the
production of ROS by inhibiting oxidases, reducing the
production of superoxide, inhibiting the oxidative modifi-
cation of low-density lipoproteins and ameliorating mito-
chondrial oxidative stress. S. miltiorrhiza also increases the
activities of catalase, manganese superoxide dismutase,
glutathione peroxidase, and coupled endothelial nitric
oxide synthase [46]. In an animal model, S. officinalis
prevented diabetes-induced acquisition and memory defi-
cits by inhibiting lipid peroxidation and enhancing
antioxidant defence systems [47].
The majority of antioxidant effects are attributed to
Salvia phenolic compounds such as rosmarinic acid, sal-
vianolic acid, sagecoumarin and sagerinic acid as they
exhibit strong radical scavenging activity with approxi-
mately 90% of 2,2-diphenylpicrylhydrazyl (DPPH) scav-
enged under the experimental conditions. In fact, their
effects were substantially greater than the sage flavonoids,
luteolin and apigenin [48]. In another in vitro study, sal-
vianolic acid L showed potent free radical scavenging
activities for DPPH and superoxide anion radicals. It was
identified as a significantly better scavenger of these free
radicals than trolox (a water-soluble analogue of vitamin
E), caffeic acid and rosmarinic acid [49].
The monoterpenes 1,8-cineole and a-pinene identified in
S. lavandulaefolia essential oil were also able to attenuate
oxidative injury in astrocytes by inhibiting ROS production
and increasing endogenous antioxidant compounds (e.g.
glutathione, catalase, superoxide dismutase, heme oxyge-
nase 1 activity and protein expression) [50]. Carnosic acid
and ursolic acid are also powerful antioxidants [51, 52].
3.5 Salvia and Anti-Inflammatory Effects
Evidence for the influence of inflammation on cognitive
function is accumulating. In animal models, the activation
of the immune system with lipopolysaccharides (LPS) [44],
a high-fat diet [53] or the non-invasive enteric pathogen,
Citrobacter rodentium [54], induced memory impairments.
In a meta-analysis, it was confirmed that an elevated level
of C-reactive protein was associated with a 45% increased
risk of all-cause dementia, and a higher level of IL-6 was
associated with a 32% increased risk. In patients with
Alzheimer’s disease, the association remained significant
but less pronounced for C-reactive protein, while there was
no association with IL-6 [55]. However, in a meta-analysis
on studies in people with mild cognitive impairment, no
significant differences in inflammatory factors with healthy
controls were identified [56]. Increased inflammation has
been demonstrated in patients with ADHD [57], and
increased inflammatory markers are associated with
decreased psychomotor speed in patients with major
depressive disorder [58], and reduced cognitive perfor-
mance in adults suffering from acute-phase psychosis [59].
Findings from in vitro and animal studies have demon-
strated that Salvia species and their constituents have anti-
inflammatory effects. An examination of the essential oils
in S. officinalis (mainly comprising 1,8-cineole and cam-
phor) revealed that it significantly inhibited nitric oxide
production stimulated by LPS in mouse macrophages [60].
Acute inflammation induced with intraperitoneal adminis-
tration of turpentine oil in mice was significantly reduced
by S. officinalis tincture, demonstrated by reductions in
total leukocyte and monocyte percentages, and the activa-
tion of circulating phagocytes [61]. Phenolic diterpenes
(carnosol and carnosic acid) present in S. officinalis
reduced nitric oxide and prostaglandin E2 (PGE2) produc-
tion in LPS-stimulated macrophages. They also signifi-
cantly blunted gene expression levels of iNOS, cytokines/
interleukins (IL-1a, IL-6) and chemokines including
CCL5/RANTES and CXCL10/IP-10 [62].
A methalonic extract of S. plebeian, and several of its
active components, significantly reduced inflammatory
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processes induced by the in vivo exposure of 12-O-te-
tradecanoylphorbol-12-acetate, and in vitro exposure to
LPS-activated macrophages. S. plebeian decreased the
release of nitric oxide, cyclooxygenase-2 (COX-2), PGE2
and the expression of iNOS [63].
Bioactive constituents contained in S. miltiorrhiza such
as the tanshinones and salvianolic acids have also been
shown to have anti-inflammatory mechanisms by influ-
encing cytokine production and iNOS activity. They also
inhibited COX-2, hypoxia-inducible factor-1a, and nuclear
factor jb activity [64]. Moreover, in one study, tanshinones
isolated from S. miltiorrhiza significantly inhibited the
mRNA and protein expression of TNF-a, IL-1b, and IL-8
in LPS-stimulated macrophages [65]. Investigations into
the constituents of Saliva plants have also confirmed that
caffeic acid, rosmarinic acid [66] and ursolic acid [51] have
strong anti-inflammatory properties.
3.6 Salvia and Antidepressant and Anxiolytic
Effects
Depression and chronic stress can have deleterious effects
on cognitive performance. In fact, cognitive deficits
including impairments in memory, attention and learning
are common symptoms of major depressive disorder and
most anxiety disorders [67]. Exposure to chronic and acute
stress can adversely affect cognitive abilities. Alzheimer’s
disease also has a high comorbidity with major depression
and it has been demonstrated that depressive symptoms can
be a prodrome to this condition [68]. Interventions that
have beneficial effects on depression and anxiety are
therefore likely to have positive effects on cognitive
performance.
The administration of hydroalcoholic extracts of S.
elegans [69] and S. verticillata [70] has been shown to
produce antidepressant and anxiolytic-like effects via ani-
mal models of depression and anxiety. The same has been
observed following the administration of essential oils of S.
sclarea [71, 72] and S. miltiorrhiza [73]. In fact, the effects
of S. sclarea were more pronounced than those obtained
from the administration of essential oils of Anthemis
nobilis (chamomile), Rosmarinus officinalis (rosemary),
and Lavandula angustifolia (lavender). The anti-stressor
effect of S. sclarea was significantly blocked by pre-
treatment with dopamine receptor antagonists, indicating
its influences via dopaminergic activity [72]. Several con-
stituents from S. officinalis also influence benzodiazepine
receptor activity, including the flavones, apigenin, hispi-
dulin and cirsimaritin; and the diterpenes, 7-methoxyros-
manol and galdosol [74].
The phenolic acids, rosmarinic acid and caffeic acid,
also possess antidepressant and anxiolytic-like activity. In a
neuropharmacological analysis, neither of these substances
affected either the uptake of monoamines to synaptosomes
or mitochondrial monoamine oxidase activity in the mouse
brain, suggesting that they produce their antidepressant
effects via mechanisms other than the inhibition of
monoamine transporters and monoamine oxidase [75, 76].
Moreover, salvianolic acid B, a compound from S. milti-
orrhiza [77], and salvinorin A from S. divinorum [78]
exhibited antidepressant and anxiolytic effects in animals
models.
4 Human Trials on the Brain-Enhancing Effects
of Salvia
The cognitive-enhancing efficacy of plants of genus Salvia
has been investigated in several human trials and are
summarised in Table 2. There have been two trials
undertaken in patients with Alzheimer’s disease, both with
preliminary, positive findings. In a pilot, open-label study,
11 patients with probable Alzheimer’s disease were
administered capsules containing 50 lL of S. lavandulae-
folia essential oil, administered 1–3 times per day over a
3-week period. Capsule intake was well tolerated, although
two patients with a history of hypertension experienced
increases in blood pressure at the highest dose. There were
statistically significant reductions in caregiver-rated neu-
ropsychiatric symptoms, and improvements in attention
over the 6-week period, although these findings were
tempered by the open-label, no-placebo arm, and small
sample size [79]. In a randomised, double-blind, placebo-
controlled study, the efficacy of an ethanolic extract of S.
officinalis was evaluated in patients with Alzheimer’s dis-
ease. In this 4-month study, participants allocated to the
active-drug condition (60 drops of S. officinalis daily)
experienced significantly greater improvements in cogni-
tive function as measured by the Alzheimer’s Disease
Assessment Scale, and the Clinical Dementia Rating Scale.
S. officinalis administration was well tolerated with no
differences in adverse effects across the active and placebo
conditions [80].
The cognitive-enhancing effects of acute, single
administration of different Salvia species has been inves-
tigated in six studies, five utilising randomised, double-
blind, placebo-controlled designs. In five studies, the effi-
cacy of Salvia plants in healthy young adults was investi-
gated, while one was conducted on healthy, older-age
volunteers. Positive cognitive (e.g. secondary memory,
attention, word recall and speed of memory) and mood-
enhancing (e.g. alertness, calmness and contentedness)
effects from the single administration of differing dosages
of essential oil of S. lavandulaefolia in healthy adults was
demonstrated [22, 81, 82]. Improvements in mood (e.g.
alertness, contentedness, and calmness) and cognition were
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also identified following the single administration of a S.
officinalis extract to healthy young adults [18], and
enhancement in memory and attention were revealed fol-
lowing the single administration of S. officinalis to healthy,
older-age adults [19]. In a randomised, single-blinded
design (participant-masked), Moss et al. [83] also found
positive cognitive and mood-enhancing effects from acute
exposure to the aroma of S. officinalis and S.
lavandulaefolia.
These studies provide preliminary support for the cog-
nitive and mood-enhancing efficacy of some Salvia spe-
cies. However, conclusions are tempered by the small
sample sizes and short treatment duration. Treatment dose,
Salvia species and extracts used have been variable, further
limiting study conclusions. Additional research is required
utilising larger populations, particularly in examining its
efficacy for the treatment of patients with Alzheimer’s
disease. Furthermore, although Salvia seems to have pos-
itive, acute, cognitive-enhancing effects, its effects over
longer-term ingestion require investigation.
5 Factors Influencing Biological Potency of Salvia
Although the influence of plants of different species of
Salvia on cognition has been reviewed, differences in the
active constituents across each species are likely to affect
their influence on biological processes and therefore their
therapeutic efficacy. Currently, the relative efficacy of dif-
ferent Salvia species on cognitive function is unknown. The
influence of individual constituents also requires further
investigation. Moreover, human studies on cognitive func-
tion have only been conducted using S. officinalis and S.
lavandulaefolia. The extracts used also varied considerably
as both essential oils and ethanolic extracts were examined.
Typical factors influencing the potency of herbal
remedies include growing, harvesting, collection, drying,
and extraction methods used. This requires consideration
when evaluating the therapeutic efficacy of Salvia plants.
For example, in an examination of the antioxidant capacity
of S. officinalis, it was found that methanolic extract yiel-
ded the highest total phenolic compounds and antioxidant
activity compared with aqueous and ethanol extracts [84].
An evaluation of antioxidant potential of 10 Salvia species
demonstrated that ethanol extracts possessed significantly
higher antioxidant capacity and total phenolic content
compared with aqueous and CO2 extraction [45]. Ratios of
amount-to-solvent, solvent temperature and duration of
immersion also influence extract potency [85]. Even the
season of Salvia plant collection is important as the highest
content of rosmarinic acid in S. officinalis leaves was
detected when collections occurred in May, July and
September [86].
6 Contraindications for the Use of Salvia
The acute administration of Salvia in healthy adults has
confirmed that its single intake is well tolerated, with no
reported adverse events. The safety profile of Salvia plants
in longer-term, human trials are summarised in Table 3.
Overall, all administered Salvia species were well toler-
ated, with only minor adverse events reported. Populations
examined included patients with Alzheimer’ disease,
menopausal women suffering from hot flushes, older-age
men undergoing treatment for prostate cancer and suffering
from hot flushes, male and female adults with type 2 dia-
betes mellitus, and male and female patients with newly
diagnosed primary hyperlipidaemia. Adverse events
reported across all studies comprising approximately 140
adult participants taking different Salvia extracts included
increased blood pressure in two patients with Alzheimer’s
disease and a history of hypertension (essential oil of S.
lavandulaefolia), infrequent reports of mild gastrointestinal
complaints (S. officinalis and S. spissum, extraction process
not detailed), and one event of acneiform skin eruption (S.
officinalis, extraction process not detailed).
The essential oils of Salvia plants do contain varying
concentrations of a and b-thujone [87]. In animal studies it
has been confirmed that thujone can be neurotoxic by
inhibiting the c-aminobutyric acid A (GABAA) receptor,
causing excitation and convulsions in a dose-dependent
manner. Although its effect in humans is uncertain, cases
of severe intoxication in humans have been reported after
consumption of essential oils rich in thujone [87]. Conse-
quently, the Committee on Herbal Medicinal Products/
European Medicines Agency (HMPC/EMA) has recom-
mended an upper daily thujone intake of 6 mg derived
from products used for medicinal purposes [88].
7 Conclusion and Directions for Future Research
Salvia plants have historically been used for the treatment
of several ailments, with traditional knowledge suggesting
they have benefits for cognitive and neurological condi-
tions. From this review it seems that the knowledge passed
on by our ancestors may have merit. Findings from
research confirm that many Salvia species and their indi-
vidual active constituents influence several biological
processes that may impact on neurological and cognitive
function. In vitro, animal and preliminary human studies
have supported the evidence of Salvia plants to enhance
cognitive skills and guard against neurodegenerative dis-
orders. However, further research is required in several
areas.
Presently, the majority of human studies have used S.
officinalis and S. lavandulaefolia species, so the efficacy of
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other Salvia species is uncertain. Moreover, the extracts
used have varied considerably across studies. Ethanolic,
methanolic and aqueous extracts have been used, along
with the essential oils of S. officinalis and S. lavandulae-
folia. The potency and pharmacodynamic effects of these
differing extracts are likely to vary considerably, poten-
tially impacting on their therapeutic efficacy. This is a
matter that requires consideration in research as the
extracts used are likely to influence outcomes. A common
issue in herbal medicine relates to differences in the quality
of extracts, making generalised conclusions about a
medicinal herb difficult. It is important that standardised,
replicable extracts be developed that include some measure
of potency and purity.
Although there have been two studies conducted on
patients with Alzheimer’s disease for a period up to
3 months, the majority of research has evaluated the
efficacy of a single administration of Salvia plants. The
efficacy of longer term intake of different Salvia species on
cognition therefore requires examination. Larger scale
clinical studies are also essential, particularly given the
initial promising findings in Alzheimer’s disease.
Several species of Salvia are commonly ingested across
numerous cultures, which increases confidence about its
safety. However, further confirmation about its safety is
necessary, particularly when ingested at higher doses.
Given the potential of neurotoxic effects from the Salvia
constituent thujone, further investigation is warranted, and/
or extracts containing little or no thujone may be prudent.
Overall, evidence for the cognitive-enhancing and pro-
tective effects of Salvia plants is promising. However,
greater investigation is essential to help us elucidate the
potential of this commonly ingested herb to enhance cog-
nitive health and wellbeing.
Table 3 Safety of Saliva plant administration in chronic human trials









30 patients with Alzheimer’s disease
with an average age of 72 years
Ethanolic extract of S.
officinalis, 60 drops daily
No difference in adverse events
between Salvia and placebo
conditions over the 4-month trial,
except for near-statistically
significant reductions in agitation
(p = 0.09) in Salvia-treated patients
Perry et al. [79] 6-week,
open-label
design
11 patients aged 76–95 years with
probable Alzheimer’s disease
50 lL essential oil of S.
lavandulaefolia, titrated to
3 capsules daily over
3 weeks
Increased blood pressure in two







69 women aged between 50 and
65 years (mean age 56 years), at
least 12 months since last
menstruation, at least five hot flushes
daily





10 adverse events among 6 patients,
of which 2 were related to study
medication (mild abdominal pain






10 prostate cancer patients (median
age 68) receiving androgen
deprivation therapy and
experiencing hot flashes
One 150-mg S. officinalis





luteinising hormone and follicular
stimulating hormone. One patient
experienced acneiform skin
eruption after 6 weeks on Salvia.
Causal connection with sage could









80 type II diabetic patients (average
age 52 years) who had not reached
the ideal control of the disease
One, 150-mg S. officinalis
tablet, 3 times daily.
Extraction process not
detailed
2 patients on active treatment
reported mild gastrointestinal














aqueous extract of S.
officinalis tablet, 3 times
daily
No reported adverse events
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